RW

Ronald Witteles

Alnylam Pharmaceuticals (United States) US

ORCID 0000-0002-3043-1472
270
Publications
13,566
Citations
49
H-Index
110
i10-Index
10.14
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes (132) Parathyroid Disorders and Treatments (60) Neuroendocrine Tumor Research Advances (30) Chemotherapy-induced cardiotoxicity and mitigation (30) Peptidase Inhibition and Analysis (29)

Affiliations

Northwestern University
US 2023 - 2023
Twitter (United States)
US 2021 - 2021
University of Colorado Hospital
US 2009 - 2009
Alnylam Pharmaceuticals (United States)
US 2026 - 2026
Oregon Health & Science University
US 2022 - 2022

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now